Reduction of Plasma BCAAs following Roux-en-Y Gastric Bypass Surgery Is Primarily Mediated by FGF21

Type 2 diabetes (T2D) is a challenging health concern worldwide. A lifestyle intervention to treat T2D is difficult to adhere, and the effectiveness of approved medications such as metformin, thiazolidinediones (TZDs), and sulfonylureas are suboptimal. On the other hand, bariatric procedures such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Harsh, Kramer, Alyssa, Mullins, Caitlyn A., Mattern, Marie, Gannaban, Ritchel B., Townsend, R. Leigh, Campagna, Shawn R., Morrison, Christopher D., Berthoud, Hans-Rudolf, Shin, Andrew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096671/
https://www.ncbi.nlm.nih.gov/pubmed/37049555
http://dx.doi.org/10.3390/nu15071713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096671/
https://www.ncbi.nlm.nih.gov/pubmed/37049555
http://dx.doi.org/10.3390/nu15071713

Ejemplares similares